Compare ARK Genomic Revolution ETF (ARKG) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs State Street SPDR S&P Homebuilders ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while State Street SPDR S&P Homebuilders ETF trades at $108.5. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | XHB | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $121.36 |
52-Week Low | $23.09 | $94.86 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XHB trades at $108.61, up 0.93% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF faces mixed housing data with June existing home sales declining 2.4% month-over-month amid record prices and mortgage rate pressures (CNBC, 2026-07-09). Key support sits at $104, while resistance is near $109. Financial ratios are unavailable in the provided data, limiting fundamental assessment.
Outlook remains cautious due to technical weakness and housing market volatility. Risks include sustained high mortgage rates and inventory constraints, though some sentiment improvement in May (CNBC, 2026-05-18) offers hope. Investors should monitor upcoming earnings from underlying holdings for clarity on profitability trends amid economic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
